Expression analysis of barrett's esophagus-associated high-grade dysplasia in laser capture microdissected archival tissue

Edmond Sabo, Patricia A. Meitner, Rosemarie Tavares, Christopher Corless, Gregory Y. Lauwers, Steven F. Moss, Murray B. Resnick

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Purpose: Identifying genes differentially expressed in nondysplastic BE (NDBE) from those expressed in high-grade dysplasia (HGD) should be of value in improving our understanding of this transition and mayyield new diagnostic and/or prognostic markers. The aim of this study was to determine the differential transcriptome of HGD compared with NDBE through gene microarray analysis of epithelial cells microdissected from archival tissue specimens. Experimental Design: Laser capture microdissection was used to isolate epithelial cells from adjacent inflammatory and stromal cells. Epithelial mRNA was extracted from areas of NDBE and HGD in matched biopsies from 11 patients. mRNA was reverse transcribed and applied on Affymetrix cDNA microarray chips customized for formalin-exposed tissue. For a subset of these genes, differential gene expression was confirmed by real-time PCR and immunohistochemistry. Results: There were 131 genes overexpressed by at least 2.5-fold in HGD versus NDBE and 16 genes that were underexpressed byat least 2.5-fold. Among the overexpressed genes are several previously shown to be increased in the neoplastic progression of BE, as well as novel genes such as lipocalin-2, S100A9, matrix metallopeptidase 12, secernin 1,and topoisomerase llα.Genes decreased in dysplastic epithelium include MUC5AC, trefoil factor 1 (TFF1), meprin A, and CD13. Real-time PCR validated the changes in expression in 24 of 28 selected genes. Immuno-histochemistry confirmed increased protein expression for topoisomerase llα,S100A9, and lipocalin-2 and decreased expression of TFF1 across the spectrum of BE-associated dysplasia from NDBE through adenocarcinoma. Conclusions: This is the first study to identify epithelial genes differentially expressed in HGD versus NDBE in matched patient samples. The genes identified include several previously implicated in the pathogenesis of BE-associated dysplasia and new candidates for further investigation.

Original languageEnglish (US)
Pages (from-to)6440-6448
Number of pages9
JournalClinical Cancer Research
Volume14
Issue number20
DOIs
StatePublished - Oct 15 2008

Fingerprint

Barrett Esophagus
Lasers
Genes
meprin A
Real-Time Polymerase Chain Reaction
Epithelial Cells
Laser Capture Microdissection
Messenger RNA
Metalloproteases
Microarray Analysis
Stromal Cells
Oligonucleotide Array Sequence Analysis
Transcriptome
Formaldehyde
Adenocarcinoma
Research Design
Epithelium
Immunohistochemistry
Biopsy
Gene Expression

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Expression analysis of barrett's esophagus-associated high-grade dysplasia in laser capture microdissected archival tissue. / Sabo, Edmond; Meitner, Patricia A.; Tavares, Rosemarie; Corless, Christopher; Lauwers, Gregory Y.; Moss, Steven F.; Resnick, Murray B.

In: Clinical Cancer Research, Vol. 14, No. 20, 15.10.2008, p. 6440-6448.

Research output: Contribution to journalArticle

Sabo, Edmond ; Meitner, Patricia A. ; Tavares, Rosemarie ; Corless, Christopher ; Lauwers, Gregory Y. ; Moss, Steven F. ; Resnick, Murray B. / Expression analysis of barrett's esophagus-associated high-grade dysplasia in laser capture microdissected archival tissue. In: Clinical Cancer Research. 2008 ; Vol. 14, No. 20. pp. 6440-6448.
@article{8d6135c69b2c4c68be396c5a02e232dd,
title = "Expression analysis of barrett's esophagus-associated high-grade dysplasia in laser capture microdissected archival tissue",
abstract = "Purpose: Identifying genes differentially expressed in nondysplastic BE (NDBE) from those expressed in high-grade dysplasia (HGD) should be of value in improving our understanding of this transition and mayyield new diagnostic and/or prognostic markers. The aim of this study was to determine the differential transcriptome of HGD compared with NDBE through gene microarray analysis of epithelial cells microdissected from archival tissue specimens. Experimental Design: Laser capture microdissection was used to isolate epithelial cells from adjacent inflammatory and stromal cells. Epithelial mRNA was extracted from areas of NDBE and HGD in matched biopsies from 11 patients. mRNA was reverse transcribed and applied on Affymetrix cDNA microarray chips customized for formalin-exposed tissue. For a subset of these genes, differential gene expression was confirmed by real-time PCR and immunohistochemistry. Results: There were 131 genes overexpressed by at least 2.5-fold in HGD versus NDBE and 16 genes that were underexpressed byat least 2.5-fold. Among the overexpressed genes are several previously shown to be increased in the neoplastic progression of BE, as well as novel genes such as lipocalin-2, S100A9, matrix metallopeptidase 12, secernin 1,and topoisomerase llα.Genes decreased in dysplastic epithelium include MUC5AC, trefoil factor 1 (TFF1), meprin A, and CD13. Real-time PCR validated the changes in expression in 24 of 28 selected genes. Immuno-histochemistry confirmed increased protein expression for topoisomerase llα,S100A9, and lipocalin-2 and decreased expression of TFF1 across the spectrum of BE-associated dysplasia from NDBE through adenocarcinoma. Conclusions: This is the first study to identify epithelial genes differentially expressed in HGD versus NDBE in matched patient samples. The genes identified include several previously implicated in the pathogenesis of BE-associated dysplasia and new candidates for further investigation.",
author = "Edmond Sabo and Meitner, {Patricia A.} and Rosemarie Tavares and Christopher Corless and Lauwers, {Gregory Y.} and Moss, {Steven F.} and Resnick, {Murray B.}",
year = "2008",
month = "10",
day = "15",
doi = "10.1158/1078-0432.CCR-08-0302",
language = "English (US)",
volume = "14",
pages = "6440--6448",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "20",

}

TY - JOUR

T1 - Expression analysis of barrett's esophagus-associated high-grade dysplasia in laser capture microdissected archival tissue

AU - Sabo, Edmond

AU - Meitner, Patricia A.

AU - Tavares, Rosemarie

AU - Corless, Christopher

AU - Lauwers, Gregory Y.

AU - Moss, Steven F.

AU - Resnick, Murray B.

PY - 2008/10/15

Y1 - 2008/10/15

N2 - Purpose: Identifying genes differentially expressed in nondysplastic BE (NDBE) from those expressed in high-grade dysplasia (HGD) should be of value in improving our understanding of this transition and mayyield new diagnostic and/or prognostic markers. The aim of this study was to determine the differential transcriptome of HGD compared with NDBE through gene microarray analysis of epithelial cells microdissected from archival tissue specimens. Experimental Design: Laser capture microdissection was used to isolate epithelial cells from adjacent inflammatory and stromal cells. Epithelial mRNA was extracted from areas of NDBE and HGD in matched biopsies from 11 patients. mRNA was reverse transcribed and applied on Affymetrix cDNA microarray chips customized for formalin-exposed tissue. For a subset of these genes, differential gene expression was confirmed by real-time PCR and immunohistochemistry. Results: There were 131 genes overexpressed by at least 2.5-fold in HGD versus NDBE and 16 genes that were underexpressed byat least 2.5-fold. Among the overexpressed genes are several previously shown to be increased in the neoplastic progression of BE, as well as novel genes such as lipocalin-2, S100A9, matrix metallopeptidase 12, secernin 1,and topoisomerase llα.Genes decreased in dysplastic epithelium include MUC5AC, trefoil factor 1 (TFF1), meprin A, and CD13. Real-time PCR validated the changes in expression in 24 of 28 selected genes. Immuno-histochemistry confirmed increased protein expression for topoisomerase llα,S100A9, and lipocalin-2 and decreased expression of TFF1 across the spectrum of BE-associated dysplasia from NDBE through adenocarcinoma. Conclusions: This is the first study to identify epithelial genes differentially expressed in HGD versus NDBE in matched patient samples. The genes identified include several previously implicated in the pathogenesis of BE-associated dysplasia and new candidates for further investigation.

AB - Purpose: Identifying genes differentially expressed in nondysplastic BE (NDBE) from those expressed in high-grade dysplasia (HGD) should be of value in improving our understanding of this transition and mayyield new diagnostic and/or prognostic markers. The aim of this study was to determine the differential transcriptome of HGD compared with NDBE through gene microarray analysis of epithelial cells microdissected from archival tissue specimens. Experimental Design: Laser capture microdissection was used to isolate epithelial cells from adjacent inflammatory and stromal cells. Epithelial mRNA was extracted from areas of NDBE and HGD in matched biopsies from 11 patients. mRNA was reverse transcribed and applied on Affymetrix cDNA microarray chips customized for formalin-exposed tissue. For a subset of these genes, differential gene expression was confirmed by real-time PCR and immunohistochemistry. Results: There were 131 genes overexpressed by at least 2.5-fold in HGD versus NDBE and 16 genes that were underexpressed byat least 2.5-fold. Among the overexpressed genes are several previously shown to be increased in the neoplastic progression of BE, as well as novel genes such as lipocalin-2, S100A9, matrix metallopeptidase 12, secernin 1,and topoisomerase llα.Genes decreased in dysplastic epithelium include MUC5AC, trefoil factor 1 (TFF1), meprin A, and CD13. Real-time PCR validated the changes in expression in 24 of 28 selected genes. Immuno-histochemistry confirmed increased protein expression for topoisomerase llα,S100A9, and lipocalin-2 and decreased expression of TFF1 across the spectrum of BE-associated dysplasia from NDBE through adenocarcinoma. Conclusions: This is the first study to identify epithelial genes differentially expressed in HGD versus NDBE in matched patient samples. The genes identified include several previously implicated in the pathogenesis of BE-associated dysplasia and new candidates for further investigation.

UR - http://www.scopus.com/inward/record.url?scp=58149194173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149194173&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-08-0302

DO - 10.1158/1078-0432.CCR-08-0302

M3 - Article

C2 - 18927283

AN - SCOPUS:58149194173

VL - 14

SP - 6440

EP - 6448

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 20

ER -